Ascendis Pharma A (ASND) EPS (Basic) (2014 - 2026)
Ascendis Pharma A (ASND) reported EPS (Basic) of $12.22 for Q1 2026, up 836.02% on a YoY basis from $1.31 in Q1 2025, and up 1967.84% sequentially from -$0.65 in Q4 2025.
Ascendis Pharma A (ASND) EPS (Basic) (2014 - 2026) Analysis & Trends
Ascendis Pharma A (ASND) has 13 years of EPS (Basic) data on file, last reported at $12.22 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 836.02% year-over-year to $12.22; the trailing twelve-month figure through Mar 2026 stood at $9.6 (up 537.07% YoY), and the FY2025 full-year result was -$4.45, up 37.08% from the prior year.
- EPS (Basic) improved to $12.22 in Q1 2026, from -$0.65 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $12.22 in Q1 2026 to a low of -$3.77 in Q4 2022.
- A 5-year average of -$0.33 and a median of -$1.56 in 2022 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) tumbled 277.34% in 2022 and jumped 836.02% in 2026, its largest moves.
- Tracing ASND's EPS (Basic) over 5 years: stood at -$3.77 in 2022, then soared by 55.24% to -$1.69 in 2023, then jumped by 57.97% to -$0.71 in 2024, then climbed by 7.9% to -$0.65 in 2025, then soared by 1967.84% to $12.22 in 2026.
- Business Quant data shows ASND's EPS (Basic) at $12.22 in Q1 2026, -$0.65 in Q4 2025, and -$1.22 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn | 12.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.22 |
| Dec 31, 2025 | -0.65 |
| Sep 30, 2025 | -1.22 |
| Jun 30, 2025 | -0.76 |
| Mar 31, 2025 | -1.66 |
| Dec 31, 2024 | -0.71 |
| Sep 30, 2024 | -1.89 |
| Jun 30, 2024 | 2.05 |
| Mar 31, 2024 | 2.50 |
| Dec 31, 2023 | -1.69 |
| Sep 30, 2023 | -3.14 |
| Jun 30, 2023 | 2.37 |
| Mar 31, 2023 | -2.14 |
| Dec 31, 2022 | -3.77 |
| Sep 30, 2022 | -3.08 |
| Jun 30, 2022 | -1.56 |
| Mar 31, 2022 | -2.48 |
| Dec 31, 2021 | -2.22 |
| Sep 30, 2021 | 1.73 |
| Jun 30, 2021 | 3.01 |